I think the company is raising $$ the best way it can...money that will be used to manufacture and ship...and sell!!!... Excellagen...the only potential revenue producing horse in the stable. That’s been on the radar screen since May of this year. I hope that’s what they’re up to 24/7 right now. Covid treatments can wait. That window has likely closed. There are 400 companies in the covid sweepstakes, many far ahead of GNBT. What THEY don’t have is Excellagen.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links